Femasys Announces FemBloc Permanent Birth Control Has Achieved MDSAP Certification, Advancing Global Market Access
-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building…
From Inspiration to Reality: The LEPAS Design Team Decodes the Birth of “Leopard Aesthetics”
WUHU, China, Nov. 20, 2025 /PRNewswire/ -- In the world of automotive…
ESHRE 41st Annual Meeting: Older paternal age linked to higher miscarriage risk and lower live birth rates in donor egg IVF cycles
A new international study presented today at the 41st Annual Meeting of…
Femasys Announces Historic Milestone with European Approval of FemBloc, the First Non-Surgical Permanent Birth Control
ATLANTA, June 25, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a…
